Navigation Links
OU researchers find way to prevent blindness in research model for retinitis pigmentosa

Researchers at the University of Oklahoma Health Sciences Center have found a way to use a radical new type of gene therapy to prevent blindness caused by retinitis pigmentosa, giving hope to the estimated 100,000 Americans who suffer from this debilitating disease.

The study appears in the Journal of the Federation of American Societies for Experimental Biology (FASEB).

The research, led by Muna Naash, Ph.D., at the University of Oklahoma Health Sciences Center, with collaborators in Cleveland and Buffalo, discovered a way to deliver known gene therapies directly to the light-sensitive cells affected by this disease.

The discovery already is being used to develop new treatments for another disease macular degeneration, the leading cause of blindness in the United States.

"I am thrilled about it. That's why we have been working so hard to get this as quickly as possible through the necessary experiments, so we can publish our findings and take it out to the patients," Naash said. "We hope the results of our study will be instrumental in generating a cure for the debilitating blindness associated with retinitis pigmentosa and other inherited and acquired retinal diseases. We want to give Oklahomans and others suffering from these diseases renewed independence and quality of life."

Utilizing nanoparticle technology, scientists created a microscopic capsule capable of carrying genetic therapies to their destination inside cells of the retina. The tiny delivery vehicle is being tested with a variety of gene therapies in animal models with the potential of treating several diseases from bladder cancer to diabetes. The capsules have proven very effective, carrying therapies to the designated location in the eye within 15 minutes of delivery and spreading the genetic repair message quickly to nearby cells.

"This is an incredible breakthrough in terms of being able to treat with gene therapy," said Robert E. Leonard, M.D., an ophthalmologist at the Dean McGee Eye Institute. "Outside of gene therapy, we are at a loss to be able to treat these patients, so this is incredibly important research. It's breathtaking, very exciting."


Contact: Diane Clay
University of Oklahoma

Related biology news :

1. Texas A&M veterinary researchers achieve cloning first
2. Researchers discover mechanism that limits scar formation
3. Researchers identify gene linked to hereditary incontinence
4. UCLA stem cell researchers uncover previously unknown patterns in DNA methylation
5. Lasers help researchers predict birds preferred habitat
6. Researchers find gene linked to birth defects
7. Yale researchers develop test to identify best sperm
8. UT Southwestern researchers use novel sperm stem-cell technique to produce genetically modified rats
9. UCI researchers create retina from human embryonic stem cells
10. Discovery may lead to safer drinking water, cheaper medicine: Queens University researchers
11. Researchers discover new mechanism for clearing blockages from smallest blood vessels
Post Your Comments:
Related Image:
OU researchers find way to prevent blindness in research model for retinitis pigmentosa
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/12/2015)... Nov. 11, 2015   Growing need for ... tools has been paving the way for use ... of discrete analytes in clinical, agricultural, environmental, food ... predominantly used in medical applications, however, their adoption ... due to continuous emphasis on improving product quality ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... and NEW YORK , November 24, ... investment by Bristol-Myers Squibb in a European ... Bristol-Myers Squibb Company in which the companies will work ... immuno-oncology and other areas of unmet medical need. The collaboration ... LSP 5, the latest LSP fund. This is the first ...
(Date:11/23/2015)... CHICAGO , Nov. 24, 2015 Women with ... screening CT exams face a higher risk of lung cancer ... being presented next week at the annual meeting of the ... --> --> Lung ... are classified as solid or subsolid based on their appearance ...
(Date:11/23/2015)... ... 23, 2015 , ... Shimadzu Corporation announces that it has ... Chromatography system. The award from R&D magazine recognizes Shimadzu’s Nexera UC system as ... the analytical and testing category. R&D Magazine chose the Nexera UC system because ...
(Date:11/23/2015)... England and PISCATAWAY, New ... Cambridge Crystallographic Data Centre (CCDC) ... the Cambridge Structural Database (CSD) and the CSD-System, ... for researchers worldwide: CSD-Discovery to support the discovery ... crystalline materials, and CSD-Enterprise, the complete set of ...
Breaking Biology Technology: